+353-1-416-8900REST OF WORLD
+44-20-3973-8888REST OF WORLD
1-917-300-0470EAST COAST U.S
1-800-526-8630U.S. (TOLL FREE)

Results for tag: "Glaucoma"

From
Cell and Gene Therapies in Ophthalmology - Product Thumbnail Image

Cell and Gene Therapies in Ophthalmology

  • Report
  • March 2024
  • 44 Pages
  • Global
From
US Contact Lenses Market Outlook to 2028 - Product Thumbnail Image

US Contact Lenses Market Outlook to 2028

  • Report
  • August 2023
  • 85 Pages
  • United States
From
From
From
From
From
Loading Indicator

Glaucoma is a group of eye diseases that damage the optic nerve, leading to vision loss. It is the leading cause of irreversible blindness worldwide. The glaucoma market within the optical industry is focused on providing treatments and technologies to diagnose and manage the disease. This includes medications, laser treatments, and surgical procedures. Additionally, the market includes devices such as tonometers, optical coherence tomography (OCT) systems, and visual field analyzers. These devices are used to measure intraocular pressure, detect structural changes in the eye, and assess the extent of vision loss. Companies in the glaucoma market include Allergan, Bausch + Lomb, Carl Zeiss Meditec, Ellex, Glaukos, Hoya, Nidek, Topcon, and Ziemer Ophthalmic Systems. Show Less Read more